Syntheon LLC develops implantable medical devices, including the Penditure™ Left Atrial Appendage Exclusion System, which enhances surgical precision in left atrial appendage management during cardiac procedures. With over 200 patents and more than $6 billion in sales, Syntheon focuses on creating solutions that improve patient outcomes and streamline surgical workflows.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
During cardiac surgery, incomplete or ineffective management of the left atrial appendage (LAA) can increase the risk of thromboembolic events, such as stroke, for patients with atrial fibrillation. Existing LAA management techniques may lack precision or require complex maneuvers, potentially prolonging surgical time and increasing patient risk.
Solution
Syntheon LLC offers the Penditure™ Left Atrial Appendage Exclusion System, a novel implantable clip designed to enhance the precision and efficiency of LAA management during concomitant cardiac surgery. The Penditure™ clip is pre-loaded on a single-use delivery system and features a curved design intended to better match the atrial anatomy. Uniquely, the device can be recaptured, repositioned, and redeployed after initial placement, giving surgeons greater control during the procedure. The clip is designed without fabric to minimize trauma and reduce inflammation.
Target Audience
The primary users are cardiac surgeons performing concomitant procedures who require precise and reliable left atrial appendage management solutions.
Features
- Pre-loaded on a single-use delivery system for streamlined surgical workflow
- Curved clip design to conform to the left atrial appendage anatomy
- Recapturable, repositionable, and redeployable functionality for precise placement
- Fabric-free design intended to minimize inflammation and thrombus formation